Premier Health Signs Agreement with CB2 Insights to Integrate Medical Cannabis Clinical Decision Support ToolPosted by On

VANCOUVER, British Columbia, Mar 27, 2019 (GLOBE NEWSWIRE via COMTEX) — Premier Health Group (otcqb:PHGRF)(frankfurt:6PH) (the “Company” or “Premier Health”), a Company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, is pleased to announce it has initiated integration of CB2 Insights’ medical cannabis Clinical Decision Support (CDS) tool.

The agreement will give the more than 4600 physicians and healthcare practitioners using Premier Health’s Juno EMR platform access to the industry’s only medical cannabis-specific CDS tool. CB2 Insights’ CDS tool is designed to help incorporate medical cannabis into their patient’s treatment plans. This first-of-its-kind integration in the medical cannabis sector will allow physicians and healthcare practitioners to…

Original Author Link click here to read complete story..



Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.